TeleClinical Care - STROKE: A randomised controlled trial of a smartphone application of care in stroke patients.

Not Applicable

Recruiting

Conditions: stroke
hypertension
Atrial Fibrillation
Stroke - Ischaemic
Stroke - Haemorrhagic
Cardiovascular - Hypertension
Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation

Registration Number: ACTRN12621000593831

Lead Sponsor: The University of New South Wales

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 700

Inclusion Criteria

•Male or female patients >18 years of age.
•Ischaemic stroke/Transient Ischaemic Attack or Primary Intracerebral Haemorrhage (Anticoagulant-Associated Haemorrhage patients are eligible) diagnosed clinically by stroke specialist, with consistent neuro-imaging results and admitted to hospital for diagnosis/treatment.
•Patient (or carer) owns a compatible smartphone and can use the app, wearables and peripherals.
•Enrolment can be performed at the time of discharge from acute care or inpatient rehabilitation
•Informed consent obtained from either the patient or substitute decision maker prior to any study related procedures being performed.

Exclusion Criteria

•Patients diagnosed with stroke mimics – such as seizures, migraine, etc.
•Patients with Intracerebral Hemorrhage (ICH) secondary to arteriovenous malformations, intracranial aneurysms, tumours or abscesses. Note: Individuals with small incidental lesions, i.e. a benign lesion such as a small meningioma, are eligible.
•Patients who will not be able to use StandingTall program (such as people who are wheelchair bound, having a physical condition that prevents exercise at home, or not feasible of using StandingTall judged by the rehabilitation team)
•Co-morbid illness with expected life expectancy of <6 months.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The rate of re-hospitalisation within 90 days of randomisation. Events will be ascertained with in person/telehealth consultations and hospital chart reviews. [ 90 days after the day of randomization.];The rate of re-hospitalisation within six months of randomisation. Events will be ascertained with in person/telehealth consultations and hospital chart reviews. [ 180 days after the day of randomisation.]

Secondary Outcome Measures